NCT00341003View on ClinicalTrials.gov

Severe Malaria and Anti-malarial Drug Resistance in Cambodia

CompletedOBSERVATIONAL
Enrollment

2,090

Participants

Timeline

Start Date

July 22, 2005

Study Completion Date

January 14, 2011

Conditions
Severe MalariaMalariaAntimalarial Drug Resistance
Trial Locations (1)

Unknown

Pursat Regional Health Center, Pursat

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00341003 - Severe Malaria and Anti-malarial Drug Resistance in Cambodia | Biotech Hunter | Biotech Hunter